Global Postpartum Hemorrhage Control Devices Market

Global Postpartum Hemorrhage Control Devices Market Size Insights Forecasts to 2035

• The Global Postpartum Hemorrhage Control Devices Market Size Was valued at USD 1.33 Billion in 2024
• The Global Postpartum Hemorrhage Control Devices Market Size is Expected to Grow at a CAGR of around 8.22% from 2025 to 2035
• The Worldwide Postpartum Hemorrhage Control Devices Market Size is Expected to Reach USD 3.17 Billion by 2035
• Asia Pacific is expected to Grow the fastest during the forecast period.

According to a Research Report Published by Decisions Advisors and Consulting, The Global Postpartum Hemorrhage Control Devices Market Size was worth around USD 1.33 Billion in 2024 and is predicted to Grow to around USD 3.17 Billion by 2035 with a compound annual growth rate (CAGR) of 8.22% from 2025 to 2035. The global postpartum hemorrhage control devices market will have future opportunities such as the growth of developing regions, the creation of inventive non-invasive devices, the incorporation of AI-enabled monitoring, the rise of maternal healthcare awareness, and the government support worldwide.

 

Market Overview

The global postpartum hemorrhage control devices market signifies the global sector dedicated to medical apparatus and innovations that prevent, control, and heal vast bleeding during and after childbirth, thus, targeting the reduction of maternal death and better maternal health conditions. The merging of digital health technologies and data analytics with PPH control devices comes along with an opportunity. The addition of intelligent monitoring systems, real-time data gathering, and remote consultation could make PPH management more effective, make it possible to detect complications at an early stage and thus allow the provision of interventions on time. Not only do these technological innovations lead to better clinical outcomes but also assist healthcare professionals in providing patient-centered and scientifically-supported care. Moreover, the tendency towards telehealth and mobile medical solutions is likely to spur the uptake of PPH control devices even more, especially in rural and disadvantaged regions.

 

Report Coverage

This research report categorizes the postpartum hemorrhage control devices market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the postpartum hemorrhage control devices market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the postpartum hemorrhage control devices market. 

 

Driving Factors

The global postpartum hemorrhage control devices market is mainly driven by the factors such as the increasing incidence of postpartum hemorrhage, the growing awareness of maternal healthcare, and the rising use of minimally invasive management devices. The development of new technologies in uterine balloon tamponade and anti-shock garments, government's support, better healthcare infrastructure, and rising demand for safe, effective, and timely maternal care are the factors that further drive the global market.

 

Restraining Factors

The global postpartum hemorrhage control devices market is constrained by several factors such as the high costs associated with the devices and procedures, lack of knowledge in the low-income areas, insufficient training of the medical staff, difficulties related to regulations, and the dominance of conventional treatments in certain medical facilities.

 

Market Segmentation

The postpartum hemorrhage control devices market share is classified into product type and application.

• The uterine balloon tamponade segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.           

Based on the product type, the postpartum hemorrhage control devices market is divided into uterine balloon tamponade, non-pneumatic anti-shock garments, uniject prefilled injection systems, and others. Among these, the uterine balloon tamponade segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The Bakri balloon and other UBT devices are widely used in both developed and developing countries because of their capability to perform quick and effective bleeding control, thus frequently avoiding surgery. Their simplicity and high rate of success are the reason why they have been accepted as a standard in the treatment of post-partum hemorrhage all over the world.   

    

    

• The hospitals segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period.     

Based on the application, the postpartum hemorrhage control devices market is divided into hospitals, clinics, ambulatory surgical centers, and others. Among these, the hospitals segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period.  The primary childbirth centers and emergency obstetric care hospitals have the most advanced care and PPH management. They have the appropriate trained staff, infrastructure, and technology for the effective management of difficult cases of blood loss after childbirth (PPH). Governments' interventions and the rising popularity of hospital births are among the factors that are driving the demand for PPH control devices in hospitals. Besides, hospitals are usually the ones that train the healthcare professionals and thus, they can take new PPH technologies easily and quickly.  

 

Regional Segment Analysis of the Postpartum Hemorrhage Control Devices Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is anticipated to hold the largest share of the postpartum hemorrhage control devices market over the predicted timeframe.

North America is anticipated to hold the largest share of the postpartum hemorrhage control devices market over the predicted timeframe.  The healthcare infrastructure of the area, along with the high level of awareness and the presence of leading market players attributed this dominance. In this regard, the United States has turned out to be an advocate for maternal health through the introduction of comprehensive programs and guidelines that stress early detection and management of PPH. Besides, the regions' dedication to R&D together with the supportive reimbursement policies are making it possible for the innovative PPH control devices to be adopted more extensively.

 

Pacific is expected to grow at a rapid CAGR in the postpartum hemorrhage control devices market during the forecast period. Rapid population growth, high birth rates, and increasing government initiatives to combat maternal mortality are key factors driving market expansion in countries such as China, India, and Indonesia. The region is also benefiting from international aid programs and public-private partnerships aimed at improving access to maternal health services. As healthcare infrastructure continues to improve and awareness about PPH management increases, the Asia Pacific market is expected to play a pivotal role in the global growth of the PPH control devices market.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the postpartum hemorrhage control devices market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

• Becton, Dickinson and Company (BD)
• Cook Medical
• Teleflex Incorporated
• Utah Medical Products, Inc.
• Zoex Corporation
• Inpress Technologies, Inc.
• 3rd Stone Design, Inc.
• Organon & Co.
• Pathfinder Health Innovations
• Qventus, Inc.
• Others

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 

Recent Development

• In 5 October 2025, WHO, FIGO, and ICM released new global recommendations that aimed to improve prevention, early diagnosis, and treatment of postpartum haemorrhage, reducing maternal deaths and saving thousands of lives worldwide.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Decisions Advisors has segmented the postpartum hemorrhage control devices market based on the below-mentioned segments: 

 

Global Postpartum Hemorrhage Control Devices Market, By Product Type

• Uterine Balloon Tamponade
• Non-Pneumatic Anti-Shock Garments
• Uniject Prefilled Injection Systems
• Others

 

Global Postpartum Hemorrhage Control Devices Market, By Application

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

 

Global Postpartum Hemorrhage Control Devices Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

 

Frequently Asked Questions (FAQ)

1. What is the CAGR of the postpartum hemorrhage control devices market over the forecast period?

A: The global postpartum hemorrhage control devices market is projected to expand at a CAGR of 8.22% during the forecast period.

 

2. What is the market size of the postpartum hemorrhage control devices market?

 A: the global postpartum hemorrhage control devices market Size is estimated to grow from USD 1.33 billion in 2024 to USD 3.17 billion by 2035, at a CAGR of 8.22% during the forecast period 2025-2035. 

  

3. Which region holds the largest share of the postpartum hemorrhage control devices market?

A: North America is anticipated to hold the largest share of the postpartum hemorrhage control devices market over the predicted timeframe.

 

4. Who are the top 10 companies operating in the global postpartum hemorrhage control devices market?

A: Becton, Dickinson and Company (BD), Cook Medical, Teleflex Incorporated, Utah Medical Products, Inc., Zoex Corporation, Inpress Technologies, Inc., 3rd Stone Design, Inc., Organon & Co., Pathfinder Health Innovations, Qventus, Inc., and Others.

 

5. What are the market trends in the postpartum hemorrhage control devices market?

A: Some of the significant market trends are the growing acceptance of minimally invasive devices for PPH management, greater knowledge of maternal healthcare, progress in technology for uterine balloon and tamponade systems, increased attention to outpatient care, and the development of healthcare infrastructure worldwide.